Literature DB >> 16985587

Finasteride and prostate cancer.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2004        PMID： 16985587      PMCID： PMC1472822     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  6 in total

1.  Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

Authors:  J C Lamb; M A Levy; R K Johnson; J T Isaacs
Journal:  Prostate       Date:  1992       Impact factor: 4.104

2.  Cell type specific expression of steroid 5 alpha-reductase 2.

Authors:  R I Silver; E L Wiley; A E Thigpen; J M Guileyardo; J D McConnell; D W Russell
Journal:  J Urol       Date:  1994-08       Impact factor: 7.450

Review 3.  Clinical and experimental studies of benign prostatic hyperplasia.

Authors:  D S Coffey; P C Walsh
Journal:  Urol Clin North Am       Date:  1990-08       Impact factor: 2.241

4.  Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans.

Authors:  A Vermeulen; V A Giagulli; P De Schepper; A Buntinx; E Stoner
Journal:  Prostate       Date:  1989       Impact factor: 4.104

5.  The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

Authors:  G J Gormley; E Stoner; R C Bruskewitz; J Imperato-McGinley; P C Walsh; J D McConnell; G L Andriole; J Geller; B R Bracken; J S Tenover
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

6.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245
  6 in total
  1 in total

1.  Steroid hormone bioavailability is controlled by the lymphatic system.

Authors:  Rahel Klossner; Michael Groessl; Nadine Schumacher; Michaela Fux; Geneviève Escher; Sophia Verouti; Heidi Jamin; Bruno Vogt; Markus G Mohaupt; Carine Gennari-Moser
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.